Results Of 5839 patients diagnosed with metastatic cancer, 395 had CUP (6.8%); 1:1 matching created a matched group of 395 CKP patients. CUP patients were less likely to receive surgery, radiation, hormonal and targeted ther- apy and more likely to receive cytotoxic empiric chemotherapeutic ...
in urban teaching hospitals.Elixhauser comorbidityscore consisted of 29 common comorbidities that could reflect the severity ofdisease burdens(excluded cancer) [23]. The principal diagnosis was categorized through the Clinical Classifications Software (CCS) for ICD-9-CM, which was a scheme that ...
Thus, although experimental studies provide novel mechanistic insights, they need to be cross-validated by adequate clinical data. To our best knowledge, there is a lack of observational data analyzing whether bone fractures will accelerate or slow down the development of breast cancer recurrence. In...
s health plan prior to the index date (30-day gap allowed); ≥2 claims for primary breast cancer (International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM):174.x) within 30 days of each other and ≥1 day apart during the 12 months prior to the index ...
Administration of radium-223 and the prognosis in Japanese bone metastatic castration-resistant prostate cancer patients: A large database study. Int. J. Urol. 2022, 29, 1079–1084. [Google Scholar] [CrossRef] [PubMed] Challita-Eid, P.M.; Satpayev, D.; Yang, P.; An, Z.; Morrison...
These data were used to identify patients with a breast cancer diagnosis International Classification of Diseases (ICD) code (ICD-9 174.x or 175.x or ICD-10 C50.x) as well as medication orders for palbociclib (Figure 1). A validated mortality endpoint was used for survival analyses [24]....